Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit

This publication has 15 references indexed in Scilit:

• Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.
  Journal of Clinical Investigation, 1986
• Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations.
  Circulation, 1986
• Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.
  Circulation, 1986
• Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.
  Circulation, 1986
• Coronary Thrombolysis with Recombinant Tissue-Type Plasminogen Activator
  Annals of Internal Medicine, 1985
• Management of patients after thrombolytic therapy for acute moycardial infarction
  Clinical Cardiology, 1985
• Plasmin inhibition of platelet function and of arachidonic acid metabolism.
  Journal of Clinical Investigation, 1985
• Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
  Circulation, 1984
• Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.
  Circulation, 1984
• Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.
  Circulation, 1984